Thank you Atherosclerosis we have learned a lot about FH with data from #SAFEHEART, showing high heterogeneity expression, improvement in LL-T and better LDL-C goals achievement, and difficulties to get them Fundación HF European Atherosclerosis Society Ateros Chile International Atherosclerosis Society (IAS)

Latam team and other collegues at European Atherosclerosis Society congress Prof Kausik Ray FMedSci Maxima Mendez ,MD,LMNLA,FHSC-EAS Ximena Reyes Pablo Corral MD Marcos Lima Martínez great opportunity to share knowledge in atherosclerosis & lipids with friends, and good moments Fundación HF Ateros Chile

Visiting International Atherosclerosis Society (IAS) booth at EAS Congress … planning and planning lot of ideas ans work to do Maxima Mendez ,MD,LMNLA,FHSC-EAS and Michelle Winokur executive Director of International Atherosclerosis Society (IAS) See you in #ISA2024OMAN Raul Santos Ateros Chile Red Iberoamericana de Hipercolesterolemia Familiar

Meeting with good friend at EAS Congress … lot of ideas to collaborate in #cardiovascular #prevention with Michael D. Shapiro President-elect of ASPC and Maxima Mendez ,MD,LMNLA,FHSC-EAS Ateros Chile International Atherosclerosis Society (IAS) European Atherosclerosis Society

There’s amazing advance in non-invasive plaque imaging ! However I’m not sure how this adds power to CAC score in risk evaluation! ⁦EAS Congress⁩ ⁦Michael D. Shapiro⁩ ⁦Khurram Nasir⁩ ⁦Michael J. Blaha⁩ ⁦Marcio S Bittencourt⁩ ⁦Ron Blankstein⁩

Great opportunity for younger investigators to attend #ISA2024Oman , see you there

Moments of the signature of the Memorandum of Understanding between Ateros Chile & Korean Society of Lipids & atherosclerosis (KSoLA) during 92 EAS Congress. Collaboration among societies is essential to grow European Atherosclerosis Society International Atherosclerosis Society (IAS)

Validated genetic target with siRNA approach with promising results #APOC3 Looking forwards to phase 3 European Atherosclerosis Society National Lipid Association Cardiometabolic Health Congress ASPC BCM Cardiology BCM_CVRI The Texas Heart Institute BCM Department of Medicine From the Labs at Baylor College of Medicine

“Nothing looks better than cardio-renal-metabolism protection: beyond weight reduction”. Rol of SGLT2 & GLP1ar in clinical practice. Symposium at XIV Clinical Nutrition, Obesity & Metabolism Conference. European Atherosclerosis Society Ateros Chile International Atherosclerosis Society (IAS)

Great session Ateros Chile & ACHINUMET during XIV conference moderating with Ada Cuevas. The importance of implementation and how tomimplement different guidelines to improve outcomes with Dra Monica Acevedo & Dr Attilio Rigotti. World Obesity EASO International Atherosclerosis Society (IAS)

An educational.program addressing #Obesity as a complex disease. Listen for International Atherosclerosis Society (IAS) experts in this series. IAS Regional.Federation ( MENA and Africa ) .

Great V Academy in Obesity organized by Ateros Chile sharing experiences in management of PwO, access to AOM, avoid stigma, QoL, clinical cases with collegues of #Concepción World Obesity EASO Ada Cuevas Sole Reyes dr phillip Foster Novo Nordisk

In remembrance of Dr. Akira Endo, a Japanese biochemist whose groundbreaking work revolutionized cardiovascular health. His discovery of statins' cholesterol-lowering properties reshaped medicine, saving countless lives. Rest peacefully, Dr. Endo.

In May, IAS partnered with European Atherosclerosis Society to host a joint symposium during #EASCongress2024 in Lyon, France. This event highlighted coronary artery disease and explored its characteristics and varied impacts on patients across different regions defined by World Health Organization (WHO).

Great initiative International Atherosclerosis Society (IAS) thanks to Peter Lansberg MDPhD and Raul Santos Lot of good info about #primaryprevention and #statins every month

El miércoles 26 de junio a las 20:00 hrs. continuaremos con el ciclo de live de Obesidad. Nuestro presidente Rodrigo Alonso Karlezi como entrevistado, conversará sobre "Obesidad y Colesterol". Actividad patrocinada por AterosChile y auspiciada por laboratorios Novo Nordisk.

Just published, #SAFEHEART showed differences in #CVrisk among 🚹&🚺with #FH followed 10 ys. Adjusted HR was 1.9 and 1.7 for #CVD & CVmortality in 🚹vs.🚺. Interesting gender differences in high risk population Fundación HF Ateros Chile International Atherosclerosis Society (IAS)

Simposio International Atherosclerosis Society (IAS) en el VIII curso de Ateros Chile excelente conferencia de Raul Santos acerca del valor predictivo de #CAC en riesgo CV y papel para intensificar tratamiento y de Attilio Rigotti acerca de #dietamediterranea y #ECV

Great 8th course of Ateros Chile endorsed by International Atherosclerosis Society (IAS). Controversies and update in Dyslipidemia, Obesity, T2DM & HTN were the topics. Amazing group of attendees. Thanks to Raul Santos for coming & sharing knowledge and experience Ada Cuevas

Efectivamente, Semaglutida está indicado para pacientes con obesidad con o sin diabetes, bastante eficaz y ha demostrado reducir #enfermedadcardiovascular. Ateros Chile International Atherosclerosis Society (IAS) Ada Cuevas Ministerio de Salud World Obesity 24 Horas